Which oral and topical nonsteroidal anti-inflammatory drugs (NSAIDs) are recommended for osteoarthritis pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended NSAIDs for Osteoarthritis

For knee and hand osteoarthritis, start with topical NSAIDs (specifically topical diclofenac or ketoprofen) before progressing to oral NSAIDs, and when oral NSAIDs are necessary, use either a standard NSAID (ibuprofen, naproxen, or diclofenac) or a COX-2 inhibitor at the lowest effective dose with a proton pump inhibitor. 1

Topical NSAIDs (First-Line for Knee and Hand OA)

Strongly recommended topical agents:

  • Topical diclofenac - Most rigorously studied with moderate effect size (NNT 9.8) 1, 2, 3, 4
  • Topical ketoprofen - Strong evidence with NNT of 6.9 2, 4

These provide efficacy similar to oral NSAIDs but with significantly better safety profiles due to minimal systemic absorption 3, 4, 5. Topical NSAIDs are particularly important for patients ≥75 years, where they are strongly recommended over oral NSAIDs 2.

The advantage is clear: local adverse events (mild skin reactions) occur more frequently than placebo, but systemic gastrointestinal and cardiovascular events are not increased 4, 6. About 60% of patients achieve substantial pain reduction with topical diclofenac or ketoprofen 4.

Oral NSAIDs (Second-Line)

When topical NSAIDs or paracetamol provide insufficient relief, oral NSAIDs are conditionally recommended 1, 2.

Specific oral NSAID selection:

Standard NSAIDs (in order of preference based on safety):

  1. Ibuprofen (1200-2400 mg/day) - Safest gastrointestinal profile, most cost-effective 7, 8
  2. Naproxen (750 mg/day) - Considered safest for cardiovascular risk 2, 9
  3. Diclofenac - Effective but higher GI toxicity than ibuprofen 7, 8

COX-2 Selective Inhibitors:

  • Celecoxib - First-line choice for OA when oral NSAIDs needed, preferred in patients with GI risk 2, 9
  • Other COX-2 inhibitors (excluding etoricoxib 60 mg) 1

Critical prescribing algorithm:

All oral NSAIDs have similar analgesic efficacy but differ in toxicity profiles 1, 9. The choice depends on individual risk factors:

  • Standard patient: Ibuprofen (lowest cost, good safety) 7
  • GI risk but no prior bleed: COX-2 inhibitor OR standard NSAID + PPI 2, 9
  • Prior GI bleed (>1 year ago): COX-2 inhibitor OR standard NSAID + PPI 2
  • Prior GI bleed (<1 year ago): COX-2 inhibitor + PPI (strongly recommended) 2
  • Cardiovascular risk: Naproxen preferred; coxibs contraindicated 2, 9
  • Age ≥75 years: Topical NSAIDs strongly preferred over oral 2

Essential Safety Measures

Always co-prescribe a proton pump inhibitor (choose lowest acquisition cost) with any oral NSAID or COX-2 inhibitor 1. This applies regardless of which oral NSAID is selected.

Use the lowest effective dose for the shortest duration 1, 9. Review need at least every 6 months and consider "as needed" rather than continuous dosing 7.

Avoid in patients taking low-dose aspirin - try other analgesics first; if NSAID necessary, must add PPI 1

Common Pitfalls

The evidence shows that all oral NSAIDs and COX-2 inhibitors have similar analgesic magnitude 1, so the selection is driven entirely by safety considerations based on age, comorbidities, and concomitant medications. Don't prescribe more expensive NSAIDs expecting better pain relief - they won't deliver it 7.

Modified-release preparations have no evidence supporting their use over standard formulations 7.

For patients with inflammatory signs (effusion), NSAIDs are logical but this specific indication lacks direct evidence 8.

References

Research

Topical NSAIDs for chronic musculoskeletal pain in adults.

The Cochrane database of systematic reviews, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.